Angel News
Angel News

Back to Homepage

20th May 2022

Biotangents secures £2.2m to accelerate rapid disease detection tech

Biotangents, a Scottish biotechnology business, has secured £2.2m of new funding made up from £1.6m from the UK Government’s Innovate UK innovation loans programme and a further £600k from a funding round lead by the investment syndicate Kelvin Capital and with Scottish Enterprise participation to support the development and roll-out of its ‘on farm’ rapid disease detection technology.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage